Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
delta 9 tetrahydrocannabinol
DRUG
2 trials
Sponsors
Yale University
, Centre for Addiction and Mental Health
Conditions
COMT Gene Polymorphism
Psychomotor Impairment
Early Phase 1
Pharmacogenetics of Cannabinoid Response
Completed
NCT00678730
Yale University
COMT Gene Polymorphism
Start: 2007-08-23
End: 2014-09-11
Updated: 2022-03-09
Unknown Phase
Combined Alcohol and Cannabis Effects on Skills of Young Drivers
Completed
NCT03106363
Centre for Addiction and Mental Health
Psychomotor Impairment
Start: 2017-07-04
End: 2020-01-17
Updated: 2026-07-24
Related Papers
The Utility of THC Cutoff Levels in Blood and Saliva for Detection of Impaired Driving.
2023-02-02
8 citations
Highs and lows of cannabinoid-dopamine interactions: effects of genetic variability and pharmacological modulation of catechol-O-methyl transferase on the acute response to delta-9-tetrahydrocannabinol in humans.
2019-06-11
4 citations
Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information.
2017-06-20
29 citations